La vendita allo scoperto per Rumble dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Rumble. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Rumble (NASDAQ:RUM) Azioni, Report sulle vendite allo scoperto

Rumble

Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.

Rumble Inc

Rumo SA

RUMBLE RESOURCES LTD by Rumble Resources Ltd.

Rumble Resources Ltd

RumbleON Inc

<p><strong>On May 5, 2025, the Audit Committee (the "Audit Committee") of the Board of Directors of Digital Ally, Inc. (the "Company") approved the dismissal of RBSM LLP ("RBSM") as the Company's independent registered public accounting firm.</strong></p>
<p>&nbsp;</p>
<p><strong>The reports of RBSM on the Company's consolidated financial statements for the fiscal years ended December 31, 2024 and 2023 did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that RBSM's reports on the consolidated financial statements of the Company as of and for the years December 31, 2024 contained an explanatory paragraph stating that "The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred substantial operating losses and will require additional capital to continue as a going concern. This raises substantial doubt about the Company's ability to continue as a going concern. Management's plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty."</strong></p>
<p>&nbsp;</p>
<p><strong>During the fiscal years ended December 31, 2024 and 2023, and through May 5, 2025, there have been no "disagreements" (as defined in Item 304(a)(1)(iv) of Regulation S-K and related instructions) with RBSM on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements if not resolved to the satisfaction of RBSM would have caused RBSM to make reference thereto in its reports on the consolidated financial statements for such years. During the fiscal years ended December 31, 2024 and 2023, and through May 5, 2025, there have been no "reportable events" (as defined in Item 304(a)(1)(v) of Regulation S-K).</strong></p>
<p>&nbsp;</p>
<p><strong>The Company provided RBSM with a copy of the disclosure it is making herein in response to Item 304(a) of Regulation S-K, and requested that RBSM to furnish the Company with a copy of its letter addressed to the Securities and Exchange Commission (the "SEC"), pursuant to Item 304(a)(3) of Regulation S-K, stating whether or not RBSM agrees with the statements related to them made by the Company in this report. A copy of RBSM's letter to the SEC dated May 7, 2025 is attached as Exhibit 16.1 to this report.</strong></p>
<p>&nbsp;</p>
<p><strong>(b) Appointment of New Independent Registered Public Accounting Firm</strong></p>
<p>&nbsp;</p>
<p><strong>On May 5, 2025, the Audit Committee approved the appointment of Victor Mokuolu CPA PLLC ("Mokuolu") as the Company's new independent registered public accounting firm, effective immediately, to perform independent audit services for the fiscal year ending December 31, 2025. During the fiscal years ended December 31, 2024 and 2023 and through May 5, 2025, neither the Company, nor anyone on its behalf, consulted Mokuolu regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered with respect to the consolidated financial statements of the Company, and no written report or oral advice was provided to the Company by Mokuolu that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue; or (ii) any matter that was the subject of a "disagreement" (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a "reportable event" (as that term is defined in Item 304(a)(1)(v) of Regulation S-K).</strong></p>


News

DGLY

Digital Ally Replaces Auditor RBSM With Victor Mokuolu CPA Despite No Disputes, Amid Going Concern Warning

<p><strong>FibroGen</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that FibroGen will report an <strong>earnings per share</strong> (EPS) of $-0.10. </p>
<p>The market awaits FibroGen's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS beat by $0.12, leading to a 21.8% drop in the share price on the subsequent day.</p>
<p>Here's a look at FibroGen's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.20</td>
<td>-0.30</td>
<td>-0.26</td>
<td>-0.42</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.08</td>
<td>-0.17</td>
<td>-0.16</td>
<td>-0.33</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-22.0%</td>
<td>-14.000000000000002%</td>
<td>5.0%</td>
<td>18.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746821173_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of FibroGen were trading at $0.3194 as of May 08. Over the last 52-week period, shares are down 74.54%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/FGEN/earnings"><strong>To track all earnings releases for FibroGen visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

FGEN

A Preview Of FibroGen's Earnings

<p>Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) is gearing up to announce its quarterly earnings on Monday, 2025-05-12. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Coherus BioSciences will report an <strong>earnings per share</strong> (EPS) of $-0.15.</p>
<p>Investors in Coherus BioSciences are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Earnings History Snapshot</h3>
<p>The company's EPS missed by $0.15 in the last quarter, leading to a 0.96% increase in the share price on the following day.</p>
<p>Here's a look at Coherus BioSciences's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.13</td>
<td>-0.12</td>
<td>-0.16</td>
<td>-0.24</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.28</td>
<td>-0.01</td>
<td>-0.14</td>
<td>-0.32</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>13.0%</td>
<td>11.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746821155_0.png" alt="eps graph" /></p>
<h3>Performance of Coherus BioSciences Shares</h3>
<p>Shares of Coherus BioSciences were trading at $0.9923 as of May 08. Over the last 52-week period, shares are down 53.6%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/CHRS/earnings"><strong>To track all earnings releases for Coherus BioSciences visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


CHRS

Earnings Preview: Coherus BioSciences

WIIM

FSLR

SEDG

Shares of solar stocks are trading higher following a report suggesting Republican lawmakers support tax credits in former President Biden's Inflation Reduction Act legislation.

<p>Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) is gearing up to announce its quarterly earnings on Monday, 2025-05-12. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Microvision will report an <strong>earnings per share</strong> (EPS) of $-0.06.</p>
<p>The announcement from Microvision is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company missed EPS by $0.05, which was followed by a 6.47% drop in the share price the next day.</p>
<p>Here's a look at Microvision's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.09</td>
<td>-0.10</td>
<td>-0.13</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.14</td>
<td>-0.07</td>
<td>-0.11</td>
<td>-0.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>3.0%</td>
<td>8.0%</td>
<td>-25.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746821093_0.png" alt="eps graph" /></p>
<h3>Market Performance of Microvision's Stock</h3>
<p>Shares of Microvision were trading at $1.15 as of May 08. Over the last 52-week period, shares are down 3.2%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Opinions on Microvision</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Microvision.</p>
<p>A total of 4 analyst ratings have been received for Microvision, with the consensus rating being Buy. The average one-year price target stands at $2.5, suggesting a potential 117.39% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of  and SmartRent, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for SmartRent, with an average 1-year price target of $1.45, suggesting a potential 26.09% upside.</li>
</ul>
<h3>Summary of Peers Analysis</h3>
<p>Within the peer analysis summary, vital metrics for  and SmartRent are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microvision</td>
<td>Buy</td>
<td>-67.65%</td>
<td>$-2.47M</td>
<td>-54.36%</td>
</tr>
<tr>
<td>SmartRent</td>
<td>Neutral</td>
<td>-18.11%</td>
<td>$13.56M</td>
<td>-14.88%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Microvision ranks lower in Revenue Growth compared to its peer. It also lags in Gross Profit and Return on Equity. Overall, Microvision's performance is below its peer in all key metrics analyzed.</p>
<h3>Discovering Microvision: A Closer Look</h3>
<p>Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.</p>
<h3>Financial Milestones: Microvision's Journey</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Microvision's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately <strong>-67.65%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Microvision's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-1888.18%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Microvision's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>-54.36%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Microvision's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-29.75%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Microvision's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.06</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/MVIS/earnings"><strong>To track all earnings releases for Microvision visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MVIS

Insights Ahead: Microvision's Quarterly Earnings

<p><strong>Assertio Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASRT#NASDAQ">ASRT</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Assertio Holdings will report an <strong>earnings per share</strong> (EPS) of $-0.06. </p>
<p>Anticipation surrounds Assertio Holdings's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.01, which was followed by a 7.46% drop in the share price the next day.</p>
<p>Here's a look at Assertio Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.05</td>
<td>-0.03</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>-8.0%</td>
<td>-12.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746821078_0.png" alt="eps graph" /></p>
<h3>Assertio Holdings Share Price Analysis</h3>
<p>Shares of Assertio Holdings were trading at $0.6394 as of May 08. Over the last 52-week period, shares are down 41.89%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/ASRT/earnings"><strong>To track all earnings releases for Assertio Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ASRT

A Look at Assertio Holdings's Upcoming Earnings Report

<p>Clarke (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CKI#TSX">CKI</a>) reported quarterly losses of $(0.17) per share. This is a 200 percent decrease over earnings of $0.17 per share from the same period last year.  The company reported $17.70 million in sales this quarter. This is a 21.23 percent increase over sales of $14.60 million the same period last year.</p>


TSX:CKI

Clarke Q1 EPS $(0.17) Down From $0.17 YoY, Sales $17.70M Up From $14.60M YoY

<p><strong>Landsea Homes</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSEA#NASDAQ">LSEA</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Landsea Homes will report an <strong>earnings per share</strong> (EPS) of $-0.03. </p>
<p>Landsea Homes bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS missed by $0.22, leading to a 8.37% increase in the share price on the subsequent day.</p>
<p>Here's a look at Landsea Homes's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.47</td>
<td>0.15</td>
<td>0.10</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.25</td>
<td>0.44</td>
<td>0.36</td>
<td>0.06</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>8.0%</td>
<td>-2.0%</td>
<td>-7.000000000000001%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746821024_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Landsea Homes were trading at $6.1 as of May 08. Over the last 52-week period, shares are down 34.83%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/LSEA/earnings"><strong>To track all earnings releases for Landsea Homes visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LSEA

An Overview of Landsea Homes's Earnings

<p><strong>Tango Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Tango Therapeutics will report an <strong>earnings per share</strong> (EPS) of $-0.38. </p>
<p>Investors in Tango Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous earnings release, the company missed EPS by $0.01, leading to a 5.05% drop in the share price the following trading session.</p>
<p>Here's a look at Tango Therapeutics's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.34</td>
<td>-0.37</td>
<td>-0.34</td>
<td>-0.31</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.35</td>
<td>-0.27</td>
<td>-0.24</td>
<td>-0.35</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-5.0%</td>
<td>-13.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746821016_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Tango Therapeutics were trading at $1.1 as of May 08. Over the last 52-week period, shares are down 84.47%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Insights on Tango Therapeutics</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Tango Therapeutics.</p>
<p>Analysts have given Tango Therapeutics a total of 1 ratings, with the consensus rating being Buy. The average one-year price target is $13.0, indicating a potential 1081.82% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of  and Tonix Pharmaceuticals, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<h3>Summary of Peers Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for  and Tonix Pharmaceuticals, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tonix Pharmaceuticals</td>
<td>Outperform</td>
<td>-31.67%</td>
<td>$1.40M</td>
<td>-20.68%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Tango Therapeutics ranks at the bottom among its peers in terms of consensus rating. It also lags behind in revenue growth and gross profit. Additionally, its return on equity is lower compared to its peers.</p>
<h3>Discovering Tango Therapeutics: A Closer Look</h3>
<p>Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.</p>
<h3>Financial Insights: Tango Therapeutics</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, Tango Therapeutics faced challenges, resulting in a decline of approximately <strong>-24.19%</strong> in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Tango Therapeutics's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-914.99%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Tango Therapeutics's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-17.57%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-11.26%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Tango Therapeutics's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.18</strong>.</p>
<p><a href="https://www.benzinga.com/quote/TNGX/earnings"><strong>To track all earnings releases for Tango Therapeutics visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


TNGX

Insights into Tango Therapeutics's Upcoming Earnings

<p>Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) is gearing up to announce its quarterly earnings on Monday, 2025-05-12. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Blink Charging will report an <strong>earnings per share</strong> (EPS) of $-0.12.</p>
<p>Blink Charging bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.01 in the last quarter, leading to a 5.99% increase in the share price on the following day.</p>
<p>Here's a look at Blink Charging's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.16</td>
<td>-0.16</td>
<td>-0.15</td>
<td>-0.24</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.15</td>
<td>-0.16</td>
<td>-0.18</td>
<td>-0.13</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>6.0%</td>
<td>-17.0%</td>
<td>-15.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820993_0.png" alt="eps graph" /></p>
<h3>Market Performance of Blink Charging's Stock</h3>
<p>Shares of Blink Charging were trading at $0.8366 as of May 08. Over the last 52-week period, shares are down 73.5%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/BLNK/earnings"><strong>To track all earnings releases for Blink Charging visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BLNK

Insights into Blink Charging's Upcoming Earnings

<p><strong>Target Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) stock has slumped 29% so far this year, extending declines after falling in each of the last three years. The seventh biggest US retailer has seen a whopping two-thirds of its market value eroded since peaking just above $129 billion in mid-2021. Fast forward to 2025, and its market capitalization is just about $44 billion.</p>
<p>Target&#8217;s steep and extended declines in the stock market potentially serves as a <a href="https://www.benzinga.com/etfs">warning for ETF investors</a> who still think highly of big-box retail.</p>
<p><strong>What Does This Mean For ETFs?</strong></p>
<ul class="wp-block-list">
<li><strong>Retail ETFs: Risk In The Aisles</strong></li>
</ul>
<p>For funds invested in Target such as the <strong>VanEck Retail ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTH#NASDAQ">RTH</a>), the retailer&#8217;s poor market performance has been a drag. A once-safe bet on middle-class spending, Target now embodies the agony of inflation-weary shoppers and the boundaries of retail automatization.</p>
<ol class="wp-block-list">
<li></li>
</ol>
<p>With peers such as <strong>Macy&#8217;s </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) also hinting at strain, these ETFs are as much at the mercy of changing U.S. consumer risks as ever.</p>
<ul class="wp-block-list">
<li><strong>Dividend ETFs: Is The Yield Worth The Risk?</strong></li>
</ul>
<p>Target continues to boast a 4.66% dividend yield, underpinned by a history of <a href="https://www.benzinga.com/quote/TGT/dividends">annual dividend increases</a>. That&#8217;s left it securely in the portfolio of <strong>VictoryShares Dividend Accelerator ETF</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSDA#NASDAQ">VSDA</a>).</p>
<ol start="2" class="wp-block-list">
<li></li>
</ol>
<p>But be warned: Target&#8217;s dividend record may be strong, but without earnings growth or investor confidence, that won&#8217;t redeem the stock&#8217;s weakness.</p>
<p><strong>What&#8217;s Happening With TGT?</strong></p>
<ol start="3" class="wp-block-list">
<li></li>
</ol>
<p>In early 2025, when Target announced a rollback of its Diversity, Equity, and Inclusion (DEI) initiatives, it sparked criticism and a 40-day boycott by consumers. That pushed Target&#8217;s stock down further till it lost about $12.4 billion in market value by February.</p>
<p>Then came the class-action lawsuit following the backlash, which accused Target of misleading investors about the risks of changing its DEI policies. </p>
<p>It didn&#8217;t end there. That was followed by uncertainty over Target&#8217;s policy on self-checkout lanes. Media reports this week hinted that Target is limiting self-checkout to thwart shoplifting. But the company says it&#8217;s merely enforcing a 10-items-or-fewer rule—a policy it rolled out quietly in March 2024, not last weekend. But the confusion adds to the image of a company grappling to fill gaps while navigating turbulent macro seas.</p>
<p>Now, with customer worries about theft, &#8220;shrink,&#8221; and subpar customer experience, the sheen of tech-savvy retail is fading. A reminder that automation, poorly executed, can shrink more than products—it can lose consumer trust.</p>
<p>And now, amid fears that <a href="https://www.benzinga.com/news/global/25/04/45017240/covid-like-shortages-empty-shelves-expected-thanks-to-trump-tariffs-experts-say">U.S. tariffs on international trade will lead to empty shop shelves</a>, Target appears to be restocking investor anxiety more than customer baskets.</p>
<p>Adding more intrigue, Senator <strong>Shelley Moore Capito </strong>recently <a href="https://www.benzinga.com/insights/government/25/05/45290762/a-congress-member-sold-up-to-30k-in-target-stock-heres-what-you-need-to-know">sold TGT shares on May 7</a>, as reported under the STOCK Act. The range of value sold was $2,002 to $30,000. Although one congressional trade isn&#8217;t gospel, investors may consider this a subtle red flag.</p>
<p><strong>Final Receipt</strong></p>
<p>Target&#8217;s <a href="https://stockanalysis.com/stocks/tgt/market-cap/?utm_source=chatgpt.com">valuation </a>crash isn&#8217;t merely a corporate fall from favor—it might just be a flashing yellow warning light for ETF investors. If you&#8217;re in it for the dividends, sector exposure, or thematic play on retail disruption, it&#8217;s time to rethink what TGT does for your portfolio. As of today, this Target may be more of a moving one.</p>
<p><strong>Read Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/etfs/new-etfs/25/05/45319298/smart-hedged-and-contrarian-invescos-new-etfs-tackle-growth-risk-value-gaps">Smart, Hedged And Contrarian: Invesco&#8217;s New ETFs Tackle Growth, Risk, Value Gaps</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>



Equities

Sector ETFs

ETFs

Merrill Lynch Retail HOLDRS Trust due 12/31/41

VSDA

Target's Self-Checkout Flip-Flop Isn't Helping After A 66% Value Crash: Are Retail ETFs Ringing Up The Real Risk?

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>D-Wave Quantum</strong>.</p>
<p>Looking at options history for D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) we detected 64 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 29% of the investors opened trades with bullish expectations and 40% with bearish.</p>
<p>From the overall spotted trades, 51 are puts, for a total amount of $2,138,942 and 13, calls, for a total amount of $674,235.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $8.0 to $15.0 for D-Wave Quantum during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for D-Wave Quantum options trades today is 3352.44 with a total volume of 204,657.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for D-Wave Quantum's big money trades within a strike price range of $8.0 to $15.0 over the last 30 days.</p>
<h3>D-Wave Quantum Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820978_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>QBTS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.75</td>
<td>$1.65</td>
<td>$1.66</td>
<td>$11.00</td>
<td>$697.2K</td>
<td>319</td>
<td>4.5K</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$5.7</td>
<td>$5.6</td>
<td>$5.6</td>
<td>$10.00</td>
<td>$112.0K</td>
<td>4.3K</td>
<td>435</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$1.4</td>
<td>$1.35</td>
<td>$1.35</td>
<td>$10.00</td>
<td>$81.0K</td>
<td>6.5K</td>
<td>3.1K</td>
</tr>
<tr>
<td>QBTS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>05/23/25</td>
<td>$1.25</td>
<td>$1.15</td>
<td>$1.2</td>
<td>$11.00</td>
<td>$60.0K</td>
<td>103</td>
<td>618</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/09/25</td>
<td>$1.2</td>
<td>$1.1</td>
<td>$1.1</td>
<td>$10.00</td>
<td>$55.0K</td>
<td>5.2K</td>
<td>3.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About D-Wave Quantum</h3>
<p>D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.</p>
<p>Having examined the options trading patterns of D-Wave Quantum, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>D-Wave Quantum's Current Market Status</h3>
<ul>
<li>With a trading volume of 154,363,182, the price of QBTS is up by 6.7%, reaching $11.12.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 90 days from now.</li>
</ul>
<h3>What Analysts Are Saying About D-Wave Quantum</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $13.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Needham persists with their Buy rating on D-Wave Quantum, maintaining a target price of $13. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for D-Wave Quantum, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

QBTS

This Is What Whales Are Betting On D-Wave Quantum

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Baidu</strong>.</p>
<p>Looking at options history for Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) we detected 9 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 44% with bearish.</p>
<p>From the overall spotted trades, 4 are puts, for a total amount of $146,961 and 5, calls, for a total amount of $336,366.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $70.0 to $120.0 for Baidu during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Baidu stands at 858.0, with a total volume reaching 1,387.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Baidu, situated within the strike price corridor from $70.0 to $120.0, throughout the last 30 days.</p>
<h3>Baidu Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820973_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$11.7</td>
<td>$11.5</td>
<td>$11.5</td>
<td>$115.00</td>
<td>$136.8K</td>
<td>466</td>
<td align="right">120</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$5.9</td>
<td>$5.7</td>
<td>$5.9</td>
<td>$105.00</td>
<td>$95.8K</td>
<td>16</td>
<td align="right">652</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$2.71</td>
<td>$2.45</td>
<td>$2.52</td>
<td>$88.00</td>
<td>$43.5K</td>
<td>994</td>
<td align="right">228</td>
</tr>
<tr>
<td>BIDU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$5.05</td>
<td>$5.0</td>
<td>$5.0</td>
<td>$90.00</td>
<td>$39.5K</td>
<td>137</td>
<td align="right">80</td>
</tr>
<tr>
<td>BIDU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$7.6</td>
<td>$7.55</td>
<td>$7.55</td>
<td>$85.00</td>
<td>$37.7K</td>
<td>1.3K</td>
<td align="right">98</td>
</tr>
</tbody>
</table>
</p>
<h3>About Baidu</h3>
<p>Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.</p>
<p>After a thorough review of the options trading surrounding Baidu, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Baidu Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,791,618, the BIDU's price is up by 0.01%, now at $87.66. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 12 days.</li>
</ul>
<h3>Professional Analyst Ratings for Baidu</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $90.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Baidu, which currently sits at a price target of $90. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Baidu with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


BIDU

What the Options Market Tells Us About Baidu

<p><strong>Quipt Home Medical</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QIPT#NASDAQ">QIPT</a>) is set to give its latest quarterly earnings report on Monday, 2025-05-12. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Quipt Home Medical will report an <strong>earnings per share</strong> (EPS) of $0.02. </p>
<p>Quipt Home Medical bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $0.03, leading to a 2.32% drop in the share price the following trading session.</p>
<p>Here's a look at Quipt Home Medical's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0</td>
<td>0.01</td>
<td>-0.01</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>-0.07</td>
<td>-0.04</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-15.0%</td>
<td>-18.0%</td>
<td>-14.000000000000002%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820972_0.png" alt="eps graph" /></p>
<h3>Quipt Home Medical Share Price Analysis</h3>
<p>Shares of Quipt Home Medical were trading at $2.14 as of May 08. Over the last 52-week period, shares are down 46.53%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/QIPT/earnings"><strong>To track all earnings releases for Quipt Home Medical visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


QIPT

Quipt Home Medical Earnings Preview

<p>Financial giants have made a conspicuous bullish move on Rocket Lab USA. Our analysis of options history for Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) revealed 18 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $74,000, and 16 were calls, valued at $850,083.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $3.0 to $30.0 for Rocket Lab USA over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Rocket Lab USA options trades today is 3249.57 with a total volume of 6,746.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Rocket Lab USA's big money trades within a strike price range of $3.0 to $30.0 over the last 30 days.</p>
<h3>Rocket Lab USA Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820968_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.78</td>
<td>$1.66</td>
<td>$1.66</td>
<td>$22.00</td>
<td>$132.8K</td>
<td>1.7K</td>
<td align="right">914</td>
</tr>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.8</td>
<td>$12.35</td>
<td>$12.8</td>
<td>$10.00</td>
<td>$102.4K</td>
<td>12.5K</td>
<td align="right">80</td>
</tr>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$2.9</td>
<td>$2.89</td>
<td>$2.9</td>
<td>$20.00</td>
<td>$98.8K</td>
<td>2.2K</td>
<td align="right">404</td>
</tr>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$6.4</td>
<td>$6.3</td>
<td>$6.33</td>
<td>$20.00</td>
<td>$63.3K</td>
<td>8.9K</td>
<td align="right">110</td>
</tr>
<tr>
<td>RKLB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.79</td>
<td>$2.73</td>
<td>$2.79</td>
<td>$20.00</td>
<td>$54.6K</td>
<td>5.1K</td>
<td align="right">578</td>
</tr>
</tbody>
</table>
</p>
<h3>About Rocket Lab USA</h3>
<p>Rocket Lab USA Inc is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, rest of the world and earns key revenue from the United States.</p>
<p>After a thorough review of the options trading surrounding Rocket Lab USA, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Rocket Lab USA Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 27,429,557, with RKLB's price down by -10.41%, positioned at $20.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 90 days.</li>
</ul>
<h3>Professional Analyst Ratings for Rocket Lab USA</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $28.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $28. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Rocket Lab USA, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


RKLB

Market Whales and Their Recent Bets on RKLB Options

<p>GAN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAN#NASDAQ">GAN</a>) reported quarterly losses of $(0.15) per share. This is a 66.67 percent decrease over losses of $(0.09) per share from the same period last year.  The company reported quarterly sales of $29.37 million which missed the analyst consensus estimate of $35.88 million by 18.16 percent.  This is a 4.19 percent decrease over sales of $30.65 million the same period last year.</p>


Earnings Misses

GAN Q1 EPS $(0.15) Down From $(0.09) YoY, Sales $29.37M Miss $35.88M Estimate

<p>Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) has outperformed the market over the past 5 years by 10.15% on an annualized basis producing an average annual return of 24.66%. Currently, Sanmina has a market capitalization of $4.31 billion. </p>
<p><strong>Buying $1000 In SANM:</strong> If an investor had bought $1000 of SANM stock 5 years ago, it would be worth <strong>$2,874.60</strong> today based on a price of $80.54 for SANM at the time of writing.</p>
<h3>Sanmina's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820957_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

SANM

$1000 Invested In Sanmina 5 Years Ago Would Be Worth This Much Today

<p>WhiteHorse Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHF#NASDAQ">WHF</a>) is preparing to release its quarterly earnings on Monday, 2025-05-12. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect WhiteHorse Finance to report an <strong>earnings per share</strong> (EPS) of $0.33.</p>
<p>Anticipation surrounds WhiteHorse Finance's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the last quarter, the company reported an EPS missed by $0.06, leading to a 0.0% drop in the share price on the subsequent day.</p>
<p>Here's a look at WhiteHorse Finance's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.400</td>
<td>0.410</td>
<td>0.44</td>
<td>0.460</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.343</td>
<td>0.394</td>
<td>0.40</td>
<td>0.465</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-5.0%</td>
<td>-5.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746820955_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of WhiteHorse Finance were trading at $9.31 as of May 08. Over the last 52-week period, shares are down 27.42%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/WHF/earnings"><strong>To track all earnings releases for WhiteHorse Finance visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: WhiteHorse Finance's Earnings Preview

<p>A political action group trying to demonstrate its hatred of <strong>Tesla Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and the company's CEO <strong>Elon Musk </strong>may have seen an experiment backfire into a sales pitch for the <a href="https://www.benzinga.com/news/23/12/36263412/watch-cybertruck-not-just-bulletproof-its-also-shopping-cart-proof-too-new-video-test-reveals">durability of the company's vehicles.</a></p>
<p><strong>What Happened</strong>: With Musk's increased role in politics in 2024 and 2025, <a href="https://www.benzinga.com/25/04/44963440/tesla-takedown-says-protests-are-working-hitting-ev-company-where-it-hurts-the-companys-bottom-line">protest groups have emerged </a>and targeted Tesla and other companies led by the world's richest man.</p>
<p>Led By Donkeys filmed a video of a Sherman tank taking on a Tesla Model 3, as reported by <a href="https://www.teslarati.com/anti-elon-musk-group-crushes-tesla-model-3-sherman-tank/">Teslarati</a>.</p>
<p>"We've crushed fascism before and we'll crush it again," World War II British army veteran <strong>Ken Turner</strong> said in the video.</p>
<p>The veteran said Musk is "using his immense power to support the far-right in Europe, and his money comes from Tesla cars."</p>
<p>The Model 3 in the video had a license plate reading "Fascism."</p>
<p>Watching the video footage shows the Model 3 held up well against the tank, with crushed windows and a crushed glass roof, but an overall surprisingly good body. The report said the vehicle looked liked the doors could still open despite being run over by a tank.</p>
<p>An M4 Sherman weighs between 66,800 to 84,000 pounds according to the report.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">EXCLUSIVE: Tesla Protest Organizer Says &#8216;Elon Musk Seems To Have Purchased The American Government&#8217;</a></strong></p>
<p><strong>Why It's Important</strong>: Tesla vehicles have become known for their durability over the years.</p>
<p>With plenty of protests against Tesla and Musk highlighting the CEO's political moves, this may not have been the right demonstration.</p>
<p>Vandalism to Tesla vehicles, which has increased in 2025, has also shown Tesla vehicles have some of the best cameras, helping with insurance claims.</p>
<p>Comments on social media about the video said a person inside the Model 3 may have been able to survive a tank running over their car.</p>
<p>In this battle of tank vs. Tesla, the round appears to have gone to Tesla.</p>
<p><strong>TSLA Price Action</strong>: Tesla stock is up 4.78% on Friday to $298.42 versus a 52-week trading range of $157.40 to $488.54. Tesla stock is down 21.6% year-to-date in 2025.</p>
<p><strong>Read Next: </strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/news/earnings/25/04/44937440/tesla-q1-misses-estimates-as-tariff-pressures-weigh-on-outlook-lower-cost-evs-still-on-track">Tesla Q1 Misses Estimates As Tariff Pressures Weigh On Outlook, Lower-Cost EVs Still On Track</a></strong></li>
</ul>
<p><em>Photo: Tesla Model 3, courtesy Tesla; Sherman tank at Utah Beach, Normandy, France, photo by Sonny Vermeer</em></p>


Entertainment

Education

TSLA

Tesla Defeats Tank? Anti-Musk Group's Experiment May Have Backfired Into A Sales Pitch

General

The Ontario Lottery And Gaming Corporation Selects Caesars Entertainment As The Service Provider In The Windsor Casino Procurement Process; This Is The Final Procurement Process In The OLG's Land-Based Gaming Modernization Initiative.

Legal

Press Releases

Trump Media CEO Devin Nunes Responds to Ruling on Brazil Attempts to Censor Rumble

Rumble Announces Purchases of $17.1 Million in Bitcoin in Accordance with Previously Announced Bitcoin Treasury Strategy

Rumble Announces Timing of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call as well as Investor Conference Participation

Rumble Unveils Rumble Live: A Linear Live Streaming Lineup

Rumble Reports Fourth Quarter and Full Year 2024 Results

Politics

Rumble & Rebel News sue MP Saks & others for conspiring to violate free speech rights

Amongst Volatility in The Markets, More Organizations Embrace Bitcoin, Adding Cryptocurrency to Their Treasury

Rumble Announces Timing of First Quarter 2025 Earnings Release and Conference Call

Rumble Reports First Quarter 2025 Results

BUCCANEERS PARTNER WITH RUMBLE CLOUD

KULR

MARA

MSTR

RIOT

Autohome Inc. American Depositary Shares, each representing four class A ordinary shares.

Autohome

Baidu, Inc. - American Depositary Shares, each representing 8 ordinary share

Baidu

Bilibili Inc. - American Depositary Shares

Bilibili

KANZHUN LIMITED - American Depository Shares

Kanzhun

CarGurus

Trump Media & Technology Group Corp. - Common Stock

Trump Media & Tech Gr

Trump Media & Technology Group Corp. - Warrants

Alphabet

Grindr

JOYY

Match Group

Pinterest

Reddit

Snap

Taboola.com

Tripadvisor

Weibo Corporation - American Depositary Shares

Weibo

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Yelp

Ziff Davis

ZoomInfo Technologies Inc. - Common Stock

Comments

Rumble

Vendite allo scoperto

Rumble (NASDAQ:RUM) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO